Vizgen Intends to Aggressively Defend Pioneering MERSCOPE Technology in Europe Just as it has in the U.S. Previous 10x Judgments Versus Competitors Have No Application to Vizgen Cases CAMBRIDGE, Mass. —-Vizgen, Inc. (“Vizgen” or the “Company”), a life science leader dedicated to improving human health by visualizing single-cell spatial genomics information, today issued the below […]
Also Files New Suit Against Vizgen’s MERSCOPE Products for Patent Infringement PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it filed new patent litigation against NanoString Technologies, Inc. (Nasdaq: NSTG) and Vizgen, Inc. in the European Unified Patent Court. 10x Genomics’ new lawsuits allege that […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced that it prevailed on a claim that Miltenyi Biotec B.V. & Co. KG commercialized antibodies it developed based on information obtained by reverse engineering Bio-Techne’s proprietary R&D Systems branded TIGIT and CCR-7 antibodies. Specifically, the Court held “it has been proven that [Miltenyi’s] TIGIT and CCR-7 antibodies are the […]
Westborough, MA – KPM Analytics, a global leader in scientific instrumentation and machinery, focused primarily on analyzing critical quality parameters in the food and agricultural industries, is gratified to announce a resounding victory in a recent jury trial concerning trade secret misappropriation claims. In the United States District Court, the jury, after an extensive examination of […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A), announced today the company intends to appeal the U.S. Patent and Trademarks Office (USPTO) Patent Trial and Appeal Board’s (PTAB) Final Written Decision in connection with the Inter Partes review (IPR) of U.S. Patent Nos. 10,337,001 & 10,900,034 (the Agilent Patents). The PTAB recently reversed the USPTO’s […]
10x Genomics is seeking additional injunctions to protect its intellectual property PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has won an injunction in its patent litigation against NanoString Technologies, Inc. (Nasdaq: NSTG) and NanoString Technologies Germany GmbH. The Munich Regional Court issued a permanent injunction […]
SEATTLE & MUNICH — NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today responded to the Regional Court of Munich’s recent decision finding that NanoString’s CosMx Spatial Molecular Imager, when used to detect RNA targets, infringes the German part of the European patent 2794928B1. The Munich […]
Patent Trial and Appeal Board Invalidates Agilent U.S. Patents 10,337,001 and 10,900,034 REDWOOD CITY, Calif. — Synthego Corp., a leading provider of genome engineering solutions, has announced a victory in its dispute with Agilent Technologies, Inc., regarding two of Agilent’s patents which have been invalidated today by a ruling of the Patent Trial and Appeal Board […]
ASDevices is pleased to reveal the filing of a new patent for the Metastable Emission Ionization Detector (MEID), a new revolutionary form of gas sensor aimed at both continuous and chromatographic applications. This new sensor will originally be used to measure ultra-trace H2O and O2 levels in the semiconductor and ultra-high purity markets. It will contend […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced that it will appeal the Federal Trade Commission’s (“FTC”) decision ordering the unwinding of Illumina’s acquisition of GRAIL. Illumina intends to file a petition for review promptly with a US Court of Appeals and will seek expedited treatment of the appeal. The FTC’s order to unwind the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
